Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2019-07-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
关于控股子公司取得医疗器械经营许可证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the acquisition of a medical device business license by a controlling subsidiary of the company. It includes details about the license, the subsidiary, and the potential impact on the company. There is no financial data, no mention of a report being attached or published, and no indication of a regulatory filing or certification. The content is an official announcement about a business operational update, which does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not related to board changes, voting results, or capital changes. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2019-07-02 Chinese
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle funds. It details contracts signed for purchasing financial products, amounts invested, returns, and current balances. The document is relatively short (2043 characters) and focuses on updates about financing activities related to cash management and investment products. It does not contain comprehensive financial statements or detailed financial performance data. It is not an annual or interim report, nor an earnings release. The content fits best under Capital/Financing Update (CAP) as it provides updates on the company's financing activities and capital management.
2019-07-01 Chinese
关于取得医疗器械注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate issued by a regulatory authority (Henan Provincial Drug Administration). It details the product name, registration number, intended use, and mentions the impact on company performance and risks. The document is short (892 characters) and is an announcement of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or governance changes. It is not a report publication announcement since it is not about publishing a report but about regulatory approval. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-07-01 Chinese
公开发行可转换公司债券网上中签结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement of the lottery results for the online subscription of convertible bonds issued by Zhengzhou Antu Bioengineering Co., Ltd. It lists the winning numbers and explains the subscription details. This is an update related to the company's financing activity, specifically about the issuance of convertible bonds and the allocation results. It is not a full financial report, audit, or management discussion. It is not a report publication announcement since it contains substantive information about the bond issuance results. Therefore, the document fits best under Capital/Financing Update (CAP). The document length is short but contains detailed allocation results, not just a notice or link to a report.
2019-07-01 Chinese
公开发行可转换公司债券网上中签率及优先配售结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the public issuance of convertible bonds by Zhengzhou Antu Bioengineering Co., Ltd. It details the subscription results, allocation to original shareholders and public investors, subscription rates, and other procedural information related to the bond issuance. There are no financial statements or detailed financial performance data included. The document is focused on the capital raising event and the allocation results of the convertible bonds issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 3807 characters, which is consistent with an announcement rather than a full report.
2019-06-30 Chinese
关于控股股东股权质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the purpose of the pledge, and risk mitigation measures. There is no financial report, earnings data, or management discussion. The content fits the category of a regulatory announcement about share pledges, which is best classified under Regulatory Filings (RNS) as it does not fit other more specific categories like Major Shareholding Notification (MRQ) or Transaction in Own Shares (POS) since it concerns a pledge, not a change in ownership or share buyback. The document length is short and it is an announcement, not a report or detailed filing.
2019-06-27 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.